Cargando…
Establishment of Prostate Tumor Growth and Metastasis Is Supported by Bone Marrow Cells and Is Mediated by PIP5K1α Lipid Kinase
SIMPLE SUMMARY: Metastatic castration-resistant PCa (mCRPC) is a clinically highly lethal disease; the mechanisms underlying the lethal disease remain poorly understood. Furthermore, no effective treatment for cancer metastasis exists. In this study, we have demonstrated that prostate cancer cells r...
Autores principales: | Karlsson, Richard, Larsson, Per, Miftakhova, Regina, Syed Khaja, Azharuddin Sajid, Sarwar, Martuza, Semenas, Julius, Chen, Sa, Hedblom, Andreas, Wang, Tianyan, Ekström-Holka, Kristina, Simoulis, Athanasios, Kumar, Anjani, Ødum, Niels, Grundström, Thomas, Persson, Jenny L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564679/ https://www.ncbi.nlm.nih.gov/pubmed/32971916 http://dx.doi.org/10.3390/cancers12092719 |
Ejemplares similares
-
FcγRIIIa receptor interacts with androgen receptor and PIP5K1α to promote growth and metastasis of prostate cancer
por: Larsson, Per Flodbring, et al.
Publicado: (2022) -
The functional interlink between AR and MMP9/VEGF signaling axis is mediated through PIP5K1α/pAKT in prostate cancer
por: Larsson, Per, et al.
Publicado: (2019) -
Targeted inhibition of ERα signaling and PIP5K1α/Akt pathways in castration‐resistant prostate cancer
por: Semenas, Julius, et al.
Publicado: (2020) -
The interplay between AR, EGF receptor and MMP-9 signaling pathways in invasive prostate cancer
por: Mandel, Anna, et al.
Publicado: (2018) -
Targeted suppression of AR-V7 using PIP5K1α inhibitor overcomes enzalutamide resistance in prostate cancer cells
por: Sarwar, Martuza, et al.
Publicado: (2016)